| Product Name |
Bosentan Inhouse Impurity 9 / 4-(tert-Butyl)-N-(5-(2-methoxyphenoxy)-6-(vinyloxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
1257099-44-7 |
| Catalog Number |
GS.35.BOS.39 |
| Chemical Name/Synonyms |
4-(1,1-Dimethylethyl)-N-[6-(ethenyloxy)-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]benzenesulfonamide; Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(ethenyloxy)-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl] |
| Molecular Weight |
533.6 |
| Molecular Formula |
C27H27N5O5S |
| Purity |
NLT 95% |
| Applications |
Bosentan is primarily prescribed to treat Pulmonary Arterial Hypertension. |
| Inventory Status |
customized
|
